United Therapeutics Corporation Deferred Tax Liabilities, Property, Plant and Equipment
United Therapeutics Corporation (UTHR) had Deferred Tax Liabilities, Property, Plant and Equipment of $74.90 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-02-25
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $74.90M.
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $64.10M.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $39.00M.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $37.40M.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment | Deferred Tax Liabilities, Property, Plant and Equipment as first filed |
|---|---|---|
| 2025-12-31 | $74.90M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $64.10M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $39.00M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $37.40M 10-K · filed 2024-02-21 | |
| 2021-12-31 | $28.20M 10-K · filed 2023-02-22 | |
| 2020-12-31 | $26.10M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $38.70M 10-K · filed 2021-02-24 | $40.70M 10-K · filed 2020-02-26 |
| 2018-12-31 | $20.20M 10-K · filed 2020-02-26 | |
| 2017-12-31 | $13.60M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $23.50M 10-K · filed 2018-02-21 | |
| 2015-12-31 | $26.50M 10-K · filed 2017-02-22 | $26.46M 10-K · filed 2016-02-25 |
| 2014-12-31 | $30.76M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $32.73M 10-K · filed 2015-02-24 | |
| 2012-12-31 | $31.43M 10-K · filed 2014-02-25 | |
| 2011-12-31 | $28.42M 10-K · filed 2013-02-26 | |
| 2010-12-31 | $23.34M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |